DEVA INSIGHTS & INDUSTRY NEWS

In the 2026 global DTC (Direct-to-Consumer) personal care export wave, competition in the hair care category has extended from a single focus on "smoothing efficacy" to "full-lifecycle safety and stability." However, when developing conditioners (especially nutrient-rich hair masks or leave-in conditioners), many brand owners frequently encounter a highly hidden and destructive supply chain disaster: 3-6 months after launch, the product suddenly develops microbial growth, thi

In the 2026 DTC haircare market, "Scalp Care as Skincare" has become an irreversible trend. However, brand owners developing shampoos often fall into a severe "cleansing and barrier health paradox": in pursuit of ultimate degreasing power and rich fragrance experiences, formulations often contain potent anionic surfactants, traditional high-risk preservatives, and high concentrations of fragrances. This leads to the excessive stripping of the stratum corneum lipid bilayer on

In the 2026 DTC haircare and skincare market, the "skinification of makeup removal" has become an irreversible trend. However, brand owners planning makeup remover product lines often fall into a severe "convenience and barrier health paradox": no-rinse makeup removers (such as micellar waters and cleansing wipes) offer ultimate convenience, but surfactant residue easily disrupts the stratum corneum lipid bilayer, triggering elevated Transepidermal Water Loss (TEWL) and close

In the 2026 DTC haircare and skincare market, "skincare-grade gentle makeup removal" has become a core growth engine. However, brand owners planning makeup remover waters or milks often fall into a severe "cleansing and gentleness paradox": pursuing strong dissolution of waterproof makeup often leads to excessive degreasing and stinging upon eye contact; shifting to ultimate gentleness faces pain points of insufficient stripping power against film-forming agents, or a fake-sm

In the 2026 DTC haircare market, "scalp microecology care" and "skincare-grade hair washing" have become core growth engines. However, brand owners planning shampoo product lines often fall into a severe "cleansing and gentleness paradox": pursuing the rich foam and low cost of SLES (Sodium Laureth Sulfate), yet leading to excessive stripping of scalp lipids, a spike in TEWL (Transepidermal Water Loss), and triggering dandruff and itching; shifting to amino acid surfactants i

In the 2026 global DTC skincare market, competition in the brightening sector has escalated from "single-ingredient marketing" to a comprehensive game of supply chain and formulation engineering. When planning product lines, brand owners often fall into the "Impossible Triangle" paradox composed of "raw material cost, formulation stability, and consumer tolerance": pursuing the ultimate gentleness and high efficacy of Glabridin, yet facing exorbitant BOM (Bill of Materials) c

Why Does Anti-Aging Serum OEM Fail on Stability Rather Than Actives? Most anti-aging serum projects fail in stability testing, not in concept selection. Retinol, signal peptides, and Pro-Xylane each carry a different failure mode: retinol oxidizes, peptides degrade under shear, and Pro-Xylane drives viscosity past the point where the system can be filled. A formula that lists all three can still lose its actives before the batch ships. The three actives also carry different c

In the 2026 global DTC skincare market, brightening is an eternal rigid demand. However, brand owners planning private-label or proprietary serums often fall into a severe "Formulation Paradox": pursuing the potent efficacy of prototype Vitamin C, yet facing extreme oxidation, yellowing, and high-pH irritation; pursuing the gentleness of Niacinamide, yet facing incompatibility with acidic ingredients and potential flushing intolerance; pursuing the potent tyrosinase inhibitio

In the 2026 global DTC skincare market, anti-aging demands have shifted from "single-ingredient worship" to "precision targeting combined with gentle, high efficacy." However, brand owners planning anti-aging product lines often fall into a severe "Formulation and Compliance Paradox": pursuing the "gold standard" efficacy of Retinol, yet facing strict concentration limits in markets like the EU (e.g., a maximum of 0.3% for leave-on products) and the risk of consumer attrition